What question did this study set out to answer?

To evaluate the potential of exome sequencing as an alternative to chromosomal microarray for diagnosing conditions like osteogenesis imperfecta.

March 21, 2026Fetal Diagnosis and Therapy0 citations

View Full Paper

Should exome sequencing Replace Chromosomal Microarray Analysis in Suspected Skeletal Dysplasias? Lessons from a Case of Osteogenesis Imperfecta

GBGustavo BetínUniversity of Cartagena MDMariana DeviaUniversity of Cartagena WAWalter AnnicchiaricoUniversity of Cartagena

Key Points

To evaluate the potential of exome sequencing as an alternative to chromosomal microarray for diagnosing conditions like osteogenesis imperfecta.
Analyzed a new COL1A1 variant related to osteogenesis imperfecta
Compared the speed and efficiency of exome sequencing and chromosomal microarray
Assessed the implications for early counseling in low-resource environments
Exome sequencing provided quicker diagnostic results compared to chromosomal microarray
Identified a novel glycine substitution variant in COL1A1
Highlighted the efficiency of exome sequencing for skeletal dysplasia cases in specific settings

Abstract

This novel COL1A1 variant reinforces the role of glycine substitutions in osteogenesis imperfecta. While chromosomal microarray remains first-tier, ES offers a faster and more efficient pathway for diagnosing suspected skeletal dysplasias, enhancing early counseling in resource-limited settings.

AI에게 질문

Bookmark

View Full Paper

AI에게 질문

Bookmark

View Full Paper

Should exome sequencing Replace Chromosomal Microarray Analysis in Suspected Skeletal Dysplasias? Lessons from a Case of Osteogenesis Imperfecta

Key Points

Abstract

Cite This Study